Regeneron says their antibody cocktail can cut the risk of death in half for some coronavirus patients
Pharmaceutical company Regeneron claims its COVID-19 antibody therapy reduces the risk of death from the coronavirus.
Pharmaceutical company Regeneron claims its COVID-19 antibody therapy reduces the risk of death from the coronavirus.
